Guardant Health
GH
#1530
Rank
NZ$23.42 B
Marketcap
NZ$180.36
Share price
2.11%
Change (1 day)
189.55%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2025 (TTM): -NZ$0.69 Billion

According to Guardant Health 's latest financial reports the company's current earnings are NZ$0.90 Billion. In 2024 the company made an earning of -NZ$0.76 Billion, an increase over its 2023 earnings that were of -NZ$0.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$0.69 Billion-8.87%
2024 -NZ$0.76 Billion-9.12%
2023 -NZ$0.83 Billion-26.73%
2022 -NZ$1.14 Billion69.96%
2021 -NZ$0.67 Billion56.35%
2020 -NZ$0.43 Billion252.69%
2019 -NZ$0.13 Billion-17.22%
2018 -NZ$0.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Natera
NTRA
-NZ$0.54 Billion-22.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-NZ$1.86 Billion 170.04%๐Ÿ‡บ๐Ÿ‡ธ USA